ArticleCurrent oncology (Toronto, Ont.)2022

Successful Treatment with Selpercatinib for Ectopic Cushing's Syndrome Due to Medullary Thyroid Cancer.

Oskar Ragnarsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.